Clinical analysis of the risk factors of slow coronary flow

Heart and Vessels

Volumn 26, Issue 5, 2011, Pages 480-486

  Xia, Shuang ^a   Deng, Song Bai ^a   Wang, Yang ^a   Xiao, Jun ^b   Du, Jian Lin ^a   Zhang, Yu ^a   Wang, Xi Chun ^a   Li, Ye Qing ^a   Zhao, Rui ^a   He, Li ^a   Xiang, Yu Luan ^a   She, Qiang ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b Chongqing Emergency Medical Center   (China)

Author keywords

Blood glucose; Inflammation; Platelet count; Slow coronary flow; Uric acid

Indexed keywords

AUTACOID; BIOLOGICAL MARKER; C REACTIVE PROTEIN; URIC ACID;

ANGIOCARDIOGRAPHY; ARTICLE; BLOOD; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; CHINA; CORONARY ARTERY BLOOD FLOW; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOLOGY; MICROCIRCULATION; NO REFLOW PHENOMENON; OBSERVER VARIATION; PATHOPHYSIOLOGY; POSTPRANDIAL STATE; PREDICTIVE VALUE; RADIOGRAPHY; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; THROMBOCYTE COUNT;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHINA; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; HUMANS; INFLAMMATION MEDIATORS; LOGISTIC MODELS; MICROCIRCULATION; NO-REFLOW PHENOMENON; OBSERVER VARIATION; PLATELET COUNT; POSTPRANDIAL PERIOD; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; URIC ACID;

EID: 84862833153     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-010-0081-5     Document Type: Article

References (45)

1. Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E (1972) Angina pectoris and slow flow velocity of dye in coronary arteries: a new angiographic finding. Am Heart J 84:66-71
2. Beltrame JF, Limaye SB, Horowitz JD (2002) The coronary slow flow phenomenon - a new coronary microvascular disorder. Cardiology 97:197-202
3. Sezgin AT, Sigirci A, Barutcu I, Topal E, Sezgin N, Ozdemir R, Yetkin E, Tandogan I, Kosar F, Ermis N, Yologlu S, Bariskaner E, Cehreli S (2003) Vascular endothelial function in patients with slow coronary flow. Coron Artery Dis 14:155-161 (Pubitemid 36543418)
4. Mosseri M, Yarom R, Gotsman, Hasin Y (1986) Histologic evidence for small vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation 74:964-972 (Pubitemid 17174942)
5. Pekdemir H, Cin VG, Ciçek D, Camsari A, Akkus N, Döven O, Parmaksiz HT (2004) Slow coronary flow may be a sign of diffuse atherosclerosis. Contribution of FFR and IVUS. Acta Cardiol 59:127-133
6. Camsari A, Ozcan T, Ozer C, Akcay B (2008) Carotid artery intima-media thickness correlates with intravascular ultrasound parameters in patients with slow coronary flow. Atherosclerosis 200:310-314
7. Selcuk H, Selcuk MT, Temizhan A, Maden O, Saydam GS, Ulupinar H, Dogan M, Aydin C, Topcu DI, Sasmaz A (2009) Decreased plasma concentrations of adiponectin in patients with slow coronary flow. Heart Vessels 24:1-7
8. Mangieri E, Macchiarelli G, Ciavolella M, Barillà F, Avella A, Martinotti A, Dell'Italia LJ, Scibilia G, Motta P, Campa PP (1996) Slow coronary flow: clinical and histopathological features in patients with otherwise normal epicardial coronary arteries. Cathet Cardiovasc Diagn 37:375-381 (Pubitemid 26100780)
9. Amasyali B, Turhan H, Kose S, Celik T, Iyisoy A, Kursaklioglu H, Isik E (2006) Aborted sudden cardiac death in a 20-year-old man with slow coronary flow. Int J Cardiol 109:427-429
10. Saya S, Hennebry TA, Lozano P, Lazzara R, Schechter E (2008) Coronary slow flow phenomenon and risk for sudden cardiac death due to ventricular arrhythmias: a case report and review of literature. Clin Cardiol 31:352-355
11. Cakmak M, Tanriverdi H, Cakmak N, Evrengul H, Cetemen S, Kuru O (2008) Simvastatin may improve myocardial perfusion abnormality in slow coronary flow. Cardiology 110:39-44
12. Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK, Braunwald E (1996) TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93:879-888 (Pubitemid 26074824)
13. Niskanen LK, Laaksonen DE, Nyyssönen K, Alfthan G, Lakka HM, Lakka TA, Salonen JT (2004) Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 164:1546-1551 (Pubitemid 38970476)
14. Ioachimescu AG, Brennan DM, Hoar BM, Hazen SL, Hoogwerf BJ (2008) Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study. Arthritis Rheum 58:623-630 (Pubitemid 351294901)
15. Yildiz A, Yilmaz R, Demirbag R, Gur M, Bas MM, Erel O (2007) Association of serum uric acid level and coronary blood flow. Coron Artery Dis 18:607-613 (Pubitemid 351339513)
16. Maxwell AJ, Bruinsma KA (2001) Uric acid is closely linked to vascular nitric oxide activity. Evidence for mechanism of association with cardiovascular disease. J Am Coll Cardiol 38:1850-1858 (Pubitemid 33116554)
17. Sezgin N, Barutcu I, Sezgin AT, Gullu H, Turkmen M, Esen AM, Karakaya O (2005) Plasma nitric oxide level and its role in slow coronary flow phenomenon. Int Heart J 46:373-382
18. Bagnati M, Perugini C, Cau C, Bordone R, Albano E, Bellomo G (1999) When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid. Biochem J 340:143-152 (Pubitemid 29251101)
19. Enli Y, Turk M, Akbay R, Evrengul H, Tanriverdi H, Kuru O, Seleci D, Kaftan A, Ozer O, Enli H (2008) Oxidative stress parameters in patients with slow coronary flow. Adv Ther 25:37-44
20. Tsai WC, Huang YY, Lin CC, Li WT, Lee CH, Chen JY, Chen JH (2009) Uric acid is an independent predictor of arterial stiffness in hypertensive patients. Heart Vessels 24:371-375
21. Patetsios P, Song M, Shutze WP, Pappas C, Rodino W, Ramirez JA, Panetta TF (2001) Identification of uric acid and xanthine oxidase in atherosclerotic plaque. Am J Cardiol 88:188-191 (Pubitemid 32607712)
22. Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q, Kang DH, Gordon KL, Watanabe S, Nakagawa T, Lan HY, Johnson RJ (2002) Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 282:991-997
23. DECODE Study Group (2001) Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161:397-405
24. Sorkin JD, Muller DC, Fleg JL, Andres R (2005) The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature. Diabetes Care 28:2626-2632 (Pubitemid 43951150)
25. Binak E, Gunduz H, Sahin M, Kurtoglu N, Dindar I (2006) The relation between impaired glucose tolerance and slow coronary flow. Int J Cardiol 111:142-146 (Pubitemid 44107551)
26. Golay A, Guitard C, Hoyer M, O Logan J, Brunel PC (2004) Assessment of postprandial glucose: relationship between a standardised continental breakfast and the oral glucose tolerance test. Br J Diabetes Vas Dis 4:321-324 (Pubitemid 39462110)
27. Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, Sakamoto T, Kugiyama K, Ogawa H, Yasue H (1999) Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 34:146-154
28. Vehkavaara S, Seppala-Lindroos A, Westerbacka J, Groop PH, Yki-Jarvinen H (1999) In vivo endothelial dysfunction characterizes patients with impaired glucose tolerance. Diabetes Care 22:2055-2060 (Pubitemid 30433988)
29. Hanefeld M, Koehler C, Schaper F, Fuecker K, Henkel E, Temelkova-Kurktschiev T (1999) Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness innon-diabetic individuals. Atherosclerosis 144:229-235 (Pubitemid 29259984)
30. Fujii N, Tsuchihashi K, Sasao H, Eguchi M, Miurakami H, Hase M, Higashiura K, Yuda S, Hashimoto A, Miura T, Ura N, Shimamoto K (2008) Insulin resistance functionally limits endothelium-dependent coronary vasodilation in nondiabetic patients. Heart Vessels 23:9-15 (Pubitemid 351276810)
31. Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF (1991) Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 84:613-617
32. Ly HQ, Kirtane AJ, Murphy SA, Buros J, Cannon CP, Braunwald E, Gibson CM, TIMI Study Group (2006) Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI Trials). Am J Cardiol 98:1-5 (Pubitemid 43902674)
33. Gökçe M, Kaplan S, Tekelioǧlu Y, Erdoǧan T, Küçükosmanoǧlu M (2005) Platelet function disorder in patients with coronary slow flow. Clin Cardiol 28:145-148
34. Sen N, Basar N, Maden O, Ozcan F, Ozlu MF, Gungor O, Cagli K, Erbay AR, Balbay Y (2009) Increased mean platelet volume in patients with slow coronary flow. Platelets 20:23-28
35. Imai T, Koike K, Kubo T, Kikuchi T, Amano Y, Takagi M, Okumura N, Nakahata T (1991) Interleukin 6 supports human megakaryocytes proliferation and differentiation in vitro. Blood 78:1969-1974
36. Asano S, Okano A, Ozawa K, Nakahata T, Ishibashi T, Koike K, Kimura H, Tanioka Y, Shibuya A, Hirano T (1990) In vivo effects of recombinant human interleukin 6 in primates: stimulated production of platelets. Blood 75:1602-1605 (Pubitemid 20145744)
37. Li JJ, Qin XW, Li ZC, Zeng HS, Gao Z, Xu B, Zhang CY, Li J (2007) Increased plasma C-reactive protein and interleukin-6 concentrations in patients with slow coronary flow. Clin Chim Acta 385:43-47 (Pubitemid 47374665)
38. Holme S, Murphy S (1981) Influence of platelet count and size on aggregation studies. J Lab Clin Med 97:623-630 (Pubitemid 11099634)
39. Taniguchi A, Fukushima M, Seino Y, Sakai M, Yoshii S, Nagasaka S, Yamauchi I, Okumura T, Nin K, Tokuyama K, Yamadori N, Ogura M, Kuroe A, Nakai Y (2003) Platelet count is independently associated with insulin resistance in non-obese Japanese type 2 diabetic patients. Metabolism 52:1246-1249 (Pubitemid 37351090)
40. Brown AS, Hong Y, de Belder A, Beacon H, Beeso J, Sherwood R, Edmonds M, Martin JF, Erusalimsky JD (1997) Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis. Arterioscler Thromb Vasc Biol 17:802-807 (Pubitemid 27169145)
41. Tannous M, Rabini RA, Vignini A, Moretti N, Fumelli P, Zielinski B, Mazzanti L, Mutus B (1999) Evidence for iNOS-dependent peroxynitrite production in diabetic platelets. Diabetologia 42:539-544 (Pubitemid 29196003)
42. Mangieri E, Tanzilli G, De Vincentis G, Barillà F, Remediani S, Acconcia MC, Comito C, Gaudio C, Scopinaro F, Puddu PE, Critelli G (2006) Slow coronary flow and stress myocardial perfusion imaging. Different patterns in acute patients. J Cardiovasc Med (Hagerstown) 7:322-327 (Pubitemid 44145634)
43. Barutcu I, Sezgin AT, Sezgin N, Gullu H, Esen AM, Topal E, Ozdemir R, Kosar F, Cehreli S (2007) Increased high sensitive CRP level and its significance in pathogenesis of slow coronary flow. Angiology 58:401-407 (Pubitemid 47301057)
44. Hein TW, Singh U, Vasquez-Vivar J, Devaraj S, Kuo L, Jialal I (2009) Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo. Atherosclerosis 206:61-68
45. Devaraj S, Yun JM, Adamson G, Galvez J, Jialal I (2009) C-reactive protein impairs the endothelial glycocalyx resulting in endothelial dysfunction. Cardiovasc Res 84:479-484